What does APOTHEEK ANDRÉ DUMONT do?

APOTHEEK ANDRÉ DUMONT is a pharmacy in Maasmechelen. Private Limited, started on 1 January 1978, 1 establishment.

What is the address of APOTHEEK ANDRÉ DUMONT?

The registered office of APOTHEEK ANDRÉ DUMONT is located at Windmolenweg(B) 92, 3631 Maasmechelen.

Is APOTHEEK ANDRÉ DUMONT still active?

Yes. According to the CBE (30 October 2026) APOTHEEK ANDRÉ DUMONT is active, legal situation “Normale toestand”, started on 1 January 1978.

Is APOTHEEK ANDRÉ DUMONT registered on Peppol?

Yes, APOTHEEK ANDRÉ DUMONT is registered on the Peppol network with ID 0208:0418632501.

What is the enterprise number of APOTHEEK ANDRÉ DUMONT?

The enterprise number of APOTHEEK ANDRÉ DUMONT is BE0418632501.

When was APOTHEEK ANDRÉ DUMONT founded?

APOTHEEK ANDRÉ DUMONT was founded on 1 January 1978.

Who are the directors of APOTHEEK ANDRÉ DUMONT?

According to the 2025 annual accounts, the directors of APOTHEEK ANDRÉ DUMONT are: PHICRO BV, INTER FARMA INVEST NV.

Is APOTHEEK ANDRÉ DUMONT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 January 1978; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK ANDRÉ DUMONT make in 2025?

APOTHEEK ANDRÉ DUMONT posted a profit after taxes of € 132,423 in financial year 2025.

What is the revenue of APOTHEEK ANDRÉ DUMONT?

As a small company, APOTHEEK ANDRÉ DUMONT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 544,713.

How much does an employee at APOTHEEK ANDRÉ DUMONT earn?

The average wage cost per full-time employee at APOTHEEK ANDRÉ DUMONT was € 57,200 in 2025: staff costs of € 308,841 for 5.4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK ANDRÉ DUMONT have?

According to the 2025 annual accounts, APOTHEEK ANDRÉ DUMONT has 5.4 full-time equivalents (FTE).

APOTHEEK ANDRÉ DUMONT (Private Limited) - Maasmechelen

Dossier APOTHEEK ANDRÉ DUMONT, printed on 30 October 2026 from databakkes.be/en/0418632501/apotheek-andre-dumont. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK ANDRÉ DUMONT from Maasmechelen, company number BE0418632501, closed financial year 2025 with a result of € 132,423 after tax. For that financial year APOTHEEK ANDRÉ DUMONT recorded a gross margin of € 544,713 and equity of € 415,644. Compared with financial year 2024, the result moved from € 63,107 to € 132,423. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Growing

€ 415,644

▲ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 132,423

▲ 110% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 70,822

▼ 12% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 125,000 paid out

94 % of the profit went to the shareholders, mostly to INTER FARMA INVEST (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

5.4

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 308,841

▼ 12% vs 2024

€ 57,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 27,338

▼ 33% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 753,310

▲ 21% vs 2024

€ 67,728 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 330,648

▼ 14% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 39,305

▼ 37% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 774,582 Gross margin 2022: € 774,582 First fiscal year in the series	€ 410,393 Gross margin 2023: € 410,393 ▼ 47% vs 2022 (€ 774,582) Unfavourable step	€ 520,019 Gross margin 2024: € 520,019 ▲ 27% vs 2023 (€ 410,393) Favourable step	€ 544,713 Gross margin 2025: € 544,713 ▲ 5% vs 2024 (€ 520,019) Favourable step	▲ 5%
Profit after taxes	€ 349,538 Profit after taxes 2022: € 349,538 First fiscal year in the series	€ 45,151 Profit after taxes 2023: € 45,151 ▼ 87% vs 2022 (€ 349,538) Unfavourable step	€ 63,107 Profit after taxes 2024: € 63,107 ▲ 40% vs 2023 (€ 45,151) Favourable step	€ 132,423 Profit after taxes 2025: € 132,423 ▲ 110% vs 2024 (€ 63,107) Favourable step	▲ 110%
Equity	€ 404,963 Equity 2022: € 404,963 First fiscal year in the series	€ 405,114 Equity 2023: € 405,114 Unchanged (€ 404,963) Favourable step	€ 408,221 Equity 2024: € 408,221 ▲ 1% vs 2023 (€ 405,114) Favourable step	€ 415,644 Equity 2025: € 415,644 ▲ 2% vs 2024 (€ 408,221) Favourable step	▲ 2%
Total debts	€ 1,274,140 Total debts 2022: € 1,274,140 First fiscal year in the series	€ 1,290,542 Total debts 2023: € 1,290,542 ▲ 1% vs 2022 (€ 1,274,140) Unfavourable step	€ 1,285,142 Total debts 2024: € 1,285,142 Unchanged (€ 1,290,542) Favourable step	€ 1,279,409 Total debts 2025: € 1,279,409 Unchanged (€ 1,285,142) Favourable step
Cash	€ 127,320 Cash 2022: € 127,320 First fiscal year in the series	€ 140,920 Cash 2023: € 140,920 ▲ 11% vs 2022 (€ 127,320) Favourable step	€ 80,166 Cash 2024: € 80,166 ▼ 43% vs 2023 (€ 140,920) Unfavourable step	€ 70,822 Cash 2025: € 70,822 ▼ 12% vs 2024 (€ 80,166) Unfavourable step	▼ 12%
Retained profit	€ 386,363 Retained profit 2022: € 386,363 First fiscal year in the series	€ 386,514 Retained profit 2023: € 386,514 Unchanged (€ 386,363) Favourable step	€ 389,621 Retained profit 2024: € 389,621 ▲ 1% vs 2023 (€ 386,514) Favourable step	€ 397,044 Retained profit 2025: € 397,044 ▲ 2% vs 2024 (€ 389,621) Favourable step	▲ 2%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 45,000 Dividend 2023: € 45,000 Unchanged (€ 0) Unchanged	€ 60,000 Dividend 2024: € 60,000 ▲ 33% vs 2023 (€ 45,000) Unchanged	€ 125,000 Dividend 2025: € 125,000 ▲ 108% vs 2024 (€ 60,000) Unchanged	▲ 108%
Bank debt	€ 803,557 Bank debt 2022: € 803,557 First fiscal year in the series	€ 735,023 Bank debt 2023: € 735,023 ▼ 9% vs 2022 (€ 803,557) Favourable step	€ 623,211 Bank debt 2024: € 623,211 ▼ 15% vs 2023 (€ 735,023) Favourable step	€ 753,310 Bank debt 2025: € 753,310 ▲ 21% vs 2024 (€ 623,211) Unfavourable step	▲ 21%
Balance sheet total	€ 1,679,104 Balance sheet total 2022: € 1,679,104 First fiscal year in the series	€ 1,695,656 Balance sheet total 2023: € 1,695,656 ▲ 1% vs 2022 (€ 1,679,104) Unchanged	€ 1,693,363 Balance sheet total 2024: € 1,693,363 Unchanged (€ 1,695,656) Unchanged	€ 1,695,053 Balance sheet total 2025: € 1,695,053 Unchanged (€ 1,693,363) Unchanged
Employees (FTE)	4.7 Employees (FTE) 2022: 4.7 First fiscal year in the series	4.3 Employees (FTE) 2023: 4.3 ▼ 0.4 vs 2022 (4.7) Unchanged	5.4 Employees (FTE) 2024: 5.4 ▲ 1.1 vs 2023 (4.3) Unchanged	5.4 Employees (FTE) 2025: 5.4 Unchanged (5.4) Unchanged

Key figures of APOTHEEK ANDRÉ DUMONT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK ANDRÉ DUMONT?

What happened at APOTHEEK ANDRÉ DUMONT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 132,423 (▲ 110% vs 2024). Source: NBB ↗
2023 PHICRO BV became a director. NBB
2023 INTER FARMA INVEST NV became a director. NBB
Jul 10, 1978 New establishment in Genk. KBO
Jan 1, 1978 Start of the company according to the CBE. KBO

In short

From € 349,538 profit in 2022 to € 132,423 profit in 2025.

Paid € 112,026 in corporate taxes since 2022.

Best year ever: 2022, with € 349,538 profit.

On average € 100,900 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

INTER FARMA INVEST 99.9%

PHICRO 0.1%

The stake of INTER FARMA INVEST, PHICRO comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK ANDRÉ DUMONT

Behind APOTHEEK ANDRÉ DUMONT are PHICRO BV and INTER FARMA INVEST NV. The shares are held by INTER FARMA INVEST (99.9%) and PHICRO (0.1%).

Directors

According to the 2025 annual accounts

PHICRO BV

Director · represented by CROUX PHILIPPE

Also active at: Apotheek Pauwengraaf

since 2023

INTER FARMA INVEST NV

Director · represented by CROUX JACOBUS

since 2023

Shareholders

INTER FARMA INVEST

99.9%

PHICRO

0.1%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Windmolenweg(B) 92

3631 Maasmechelen

2.015.185.589

André Dumontlaan 50

3600 Genk

Active since 10 July 1978

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

SACRO

€ 116,293 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0418.632.501

VAT number

BE 0418.632.501

Registered office

Windmolenweg(B) 92, 3631 Maasmechelen

Names & denominations

APOTHEEK ANDRÉ DUMONT

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 January 1978

Peppol

Active · Active since 27 Nov 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK ANDRÉ DUMONT

Financials

What happened to APOTHEEK ANDRÉ DUMONT?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions